PA
RYN icon

PharVision Advisers’s Rayonier RYN Stock Holding History

PharVision Advisers’s Portfolio RYN Stock Details RYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,116
Closed -$332K – 968
2025
Q3 		$332K Buy
+13,116
New +$315K 0.19% 168
2025
Q2 		– Sell
-15,877
Closed -$422K – 407
2025
Q1 		$422K Sell
15,877
-3,969
-20% -$101K 0.59% 27
2024
Q4 		$494K Buy
+19,846
New +$553K 0.42% 43

Other funds holding RYN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Cohen & Steers
Cohen & Steers New York $63.2B AUM 17.15% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $16B AUM 37.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

PharVision Advisers's RYN Position: Q4 2025 in Review

PharVision Advisers sold out of Rayonier (RYN) in Q4 2025, closing a stake of 13,116 shares — an estimated $332K sold.

PharVision Advisers first reported a position in RYN in Q4 2024 and held it in 3 quarters. The position peaked at $494K in Q4 2024. 360 funds tracked by Wall St. Rank hold RYN as of Q4 2025.

  • PharVision Advisers reported no remaining Rayonier position as of Q4 2025 after selling out during the quarter.
  • PharVision Advisers sold 13,116 Rayonier shares in Q4 2025, an estimated $332K.
  • PharVision Advisers first reported a position in Rayonier in Q4 2024 and held it in 3 quarters.
  • PharVision Advisers's Rayonier position peaked at $494K in Q4 2024.
  • 360 funds tracked by Wall St. Rank held Rayonier as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.